IRIS
LICCI, ALBERTO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 543
EU - Europa 262
AS - Asia 146
AF - Africa 9
Continente sconosciuto - Info sul continente non disponibili 1
SA - Sud America 1
Totale 962
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 542
UA - Ucraina 70
TR - Turchia 60
IE - Irlanda 37
IT - Italia 37
SG - Singapore 36
SE - Svezia 34
DE - Germania 28
DK - Danimarca 27
CN - Cina 23
FI - Finlandia 15
KR - Corea 14
FR - Francia 12
HK - Hong Kong 11
CI - Costa d'Avorio 9
CA - Canada 1
CL - Cile 1
CY - Cipro 1
EE - Estonia 1
EU - Europa 1
PT - Portogallo 1
VN - Vietnam 1
Totale 962
Salva come PNG Salva come JPEG
Città #
Chandler 87
Jacksonville 70
Fairfield 58
Dublin 37
Boardman 32
Wilmington 29
Cambridge 28
Ashburn 26
Woodbridge 24
Singapore 22
Houston 20
Seattle 19
New York 15
Lawrence 14
Princeton 14
San Mateo 14
Turin 13
Hong Kong 11
Abidjan 9
Des Moines 7
Beijing 6
Ann Arbor 4
Izmir 4
Norwalk 3
San Diego 3
Guangzhou 2
Los Angeles 2
Shanghai 2
Clifton 1
Helsinki 1
Kunshan 1
Lisbon 1
Nicosia 1
Pesaro 1
Santa Clara 1
Tallinn 1
Toronto 1
Wuhan 1
Wuxi 1
Totale 586
Salva come PNG Salva come JPEG
Nome #
In vitro activity of citropin 1.1 alone and in combination with clinically used antimicrobial agents against Rhodococcus equi. 81
Comparative efficacies of quinupristin-dalfopristin, linezolid, vancomycin, and ciprofloxacin in treatment, using the antibiotic-lock technique, of experimental catheter-related infection due to Staphylococcus aureus. 81
Temporin A alone and in combination with imipenem reduces lethality in a mouse model of staphylococcal sepsis. 77
In vitro activity of MSI-78 alone and in combination with antibiotics against bacteria responsible for bloodstream infections in neutropenic patients. 76
In vitro activity of amphibian peptides alone and in combination with antimicrobial agents against multidrug-resistant pathogens isolated from surgical wound infection. 74
In vitro activities of tritrpticin alone and in combination with other antimicrobial agents against Pseudomonas aeruginosa. 71
Pre-treatment of central venous catheters with the cathelicidin BMAP-28 enhances the efficacy of antistaphylococcal agents in the treatment of experimental catheter-related infection. 71
In vitro activity of the histatin derivative P-113 against multidrug-resistant pathogens responsible for pneumonia in immunocompromised patients. 69
In vitro activity and killing effect of citropin 1.1 against gram-positive pathogens causing skin and soft tissue infections. 67
Comparative efficacy of quinupristin/dalfopristin, linezolid, vancomycin and ciprofloxacin in the treatment of experimental catheter-related infection due to Staphylococcus aureus using the antibiotic-lock technique 66
In vitro activities of the lipopeptides palmitoyl (Pal)-Lys-Lys-NH(2) and Pal-Lys-Lys alone and in combination with antimicrobial agents against multiresistant gram-positive cocci. 63
LL-37 protects rats against lethal sepsis caused by gram-negative bacteria. 63
RNAIII-inhibiting peptide significantly reduces bacterial load and enhances the effect of antibiotics in the treatment of central venous catheter-associated Staphylococcus aureus infections. 59
Pretreatment with the protegrin IB-367 affects Gram-positive biofilm and enhances the therapeutic efficacy of linezolid in animal models of central venous catheter infection. 55
Totale 973
Salva come PNG Salva come JPEG
Categoria #
all - tutte 5.066
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 5.066
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202056 0 0 0 0 0 0 14 0 14 0 1 27
2020/2021227 18 23 30 3 25 19 18 25 18 21 18 9
2021/202298 14 15 0 1 0 13 3 4 5 20 2 21
2022/2023234 14 37 14 18 15 22 1 14 60 1 32 6
2023/202488 21 1 3 18 16 17 1 0 0 0 0 11
2024/202595 27 14 13 2 16 13 10 0 0 0 0 0
Totale 973